Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

DiaMedica Therapeutics (DMAC) Return on Invested Capital (2018 - 2026)

DiaMedica Therapeutics filings provide 9 years of Return on Invested Capital readings, the most recent being 0.01% for Q1 2026.

  • Quarterly Return on Invested Capital fell 1.0% to 0.01% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.01% through Mar 2026, down 1.0% year-over-year, with the annual reading at 0.01% for FY2025, 1.0% down from the prior year.
  • Return on Invested Capital hit 0.01% in Q1 2026 for DiaMedica Therapeutics, down from 0.01% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.0% in Q4 2024 and bottomed at 0.01% in Q1 2026.
  • Average Return on Invested Capital over 5 years is 0.0%, with a median of 0.0% recorded in 2023.
  • The largest annual shift saw Return on Invested Capital changed 0bps in 2022 before it dropped -1bps in 2025.
  • DiaMedica Therapeutics' Return on Invested Capital stood at 0.0% in 2022, then rose by 5bps to 0.0% in 2023, then skyrocketed by 79bps to 0.0% in 2024, then crashed by -673bps to 0.01% in 2025, then fell by -11bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Return on Invested Capital are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025).